Intestinal gas: Has diet anything to do in the absence of a demonstrable malabsorption state?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 5, 2012, Pages 489-493

  Serra, Jordi ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; CARBOHYDRATE; PREBIOTIC AGENT; PROBIOTIC AGENT;

ABDOMINAL DISEASE; BLOATING; DIET RESTRICTION; ENTERITIS; FERMENTATION; HEART DISEASE; HUMAN; HYPERALGESIA; LACTOBACILLUS; MALABSORPTION; NONHUMAN; PNEUMATOSIS INTESTINALIS; REVIEW; VISCERAL HYPERALGESIA;

CAPSAICIN; DIET; DIETARY CARBOHYDRATES; DIETARY FIBER; ENTEROBACTERIACEAE; GASES; HUMANS; HYPERALGESIA; INTESTINAL DISEASES; INTESTINES; IRRITABLE BOWEL SYNDROME; MALABSORPTION SYNDROMES; PREBIOTICS; PROBIOTICS;

ENTEROBACTERIACEAE; LACTOBACILLUS;

EID: 84865522660     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328356662d     Document Type: Review

References (37)

1. Agrawal A, Whorwell PJ. Review article: abdominal bloating and distension in functional gastrointestinal disorders - epidemiology and exploration of possible mechanisms. Aliment Pharmacol Ther 2008; 27:2-10. (Pubitemid 350212628)
2. Lembo T, Naliboff B, Munakata J, et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999; 94:1320-1326. (Pubitemid 29214648)
3. Azpiroz F, Bouin M, Camilleri M, et al. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007; 19:62-88. (Pubitemid 46058983)
4. Levitt MD, Hirsh P, Fetzer CA, et al. H2 excretion after ingestion of complex carbohydrates. Gastroenterology 1987; 92:383-389.
5. Suarez F, Levitt MD. Intestinal gas. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology/diagnosis/management, 7th ed. Philadelphia, PA: W.B. Saunders Co; 2002. pp. 155-163
6. Tomlin J, Lowis C, Read NW. Investigation of normal flatus production in healthy volunteers. Gut 1991; 32:665-669.
7. King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998; 352:1187-1189. (Pubitemid 28458534)
8. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003; 98:412-419. (Pubitemid 36232393)
9. Madden JA, Hunter JO. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr 2002; 88 (Suppl.1): S67-S72. (Pubitemid 35251945)
10. Quigley EM. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. Nutr Clin Pract 2012; 27:195-200.
11. Tack J, Muller-Lissner S, Stanghellini V, et al. Diagnosis and treatment of chronic constipation - a European perspective. Neurogastroenterol Motil 2011; 23:697-710.
12. U.S. Department of Agriculture, and U.S. Department of Health and Human Services: Dietary Guidelines for Americans 2010. 7 edition. Washington D.C. US. Government Printing Office, December: 2010.
13. Winham DM, Hutchins AM. Perceptions of flatulence from bean consumption among adults in 3 feeding studies. Nutr J 2011; 10:128-137.
14. Kellow JE, Azpiroz F, Delvaux M, et al. Principles of applied neurogastroenterology: physiology/motility-sensation. In: Drossman DA, Corazziari E, Delvaux M, et al., editors. The functional gastrointestinal disorders, 3rd ed. Mc Lean, VA: Degnon Associates; 2006. pp.89-160.
15. Staudacher HM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 2011; 24:487-495.
16. Cummings JH, Macfarlane GT, Englyst HN. Prebiotic digestion and fermentation. Am J Clin Nutr 2001; 73:415S-420S. (Pubitemid 32113265)
17. Rose DJ, Venema K, Keshavarzian A, Hamaker BR. Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease. Br J Nutr 2010; 103:1514-1524.
18. Kaur A, Rose DJ, Rumpagaporn P, et al. In vitro batch fecal fermentation comparison of gas and short-chain fatty acid production using 'slowly fermentable' dietary fibers. J Food Sci 2011; 76:H137-H142.
19. Holzer P. TRP channels in the digestive system. Curr Pharm Biotechnol 2011; 12:24-34.
20. Bortolotti M, Porta S. Effect of red pepper on symptoms of irritable bowel syndrome: preliminary study. Dig Dis Sci 2011; 56:3288-3295.
21. Guo H, Jiang T, Wang J, et al. The value of eliminating foods according to food-specific immunoglobulin G antibodies in irritable bowel syndrome with diarrhoea. J Int Med Res 2012; 40:204-210.
22. Savino F, Cordisco L, Tarasco V, et al. Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants. BMC Microbiol 2011; 11:157-163.
23. Ciacci C, Franceschi F, Purchiaroni F, et al. Effect of beta-glucan, inositol and digestive enzymes in GI symptoms of patients with IBS. Eur Rev Med Pharmacol Sci 2011; 15:637-643.
24. Sudha MR, Sawant P. Effect of capsule 'UB03' containing potential probiotic strains for the treatment of patients with irritable bowel syndrome. Benef Microbes 2011; 2:229-233.
25. Ringel-Kulka T, Palsson OS, Maier D, et al. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a doubleblind study. J Clin Gastroenterol 2011; 45:518-525.
26. Tarrerias AL, Costil V, Vicari F, et al. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. Dig Dis 2011; 29:588-591.
27. Serra J, Azpiroz F, Malagelada JR. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 2001; 48:14-19. (Pubitemid 32042636)
28. Caldarella MP, Serra J, Azpiroz F, Malagelada JR. Prokinetic effects in patients with intestinal gas retention. Gastroenterology 2002; 122:1748-1755. (Pubitemid 34651417)
29. Salvioli B, Serra J, Azpiroz F, et al. Origin of gas retention and symptoms in patients with bloating. Gastroenterology 2005; 128:574-579. (Pubitemid 40585358)
30. Hernando-Harder AC, Serra J, Azpiroz F, et al. Colonic responses to gas loads in subgroups of patients with abdominal bloating. Am J Gastroenterol 2010; 105:876-882.
31. Harder H, Serra J, Azpiroz F, Malagelada JR. Reflex control of intestinal gas dynamics and tolerance in humans. Am J Physiol Gastrointest Liver Physiol 2004; 286:G89-G94. (Pubitemid 38055841)
32. Serra J, Azpiroz F, Malagelada JR. Gastric distension and duodenal lipid infusion modulate intestinal gas transit and tolerance in humans. Am J Gastroenterol 2002; 97:2225-2230.
33. Passos MC, Serra J, Azpiroz F, et al. Impaired reflex control of intestinal gas transit in patients with abdominal bloating. Gut 2005; 54:344-348. (Pubitemid 40299089)
34. Serra J, Salvioli B, Azpiroz F, Malagelada JR. Lipid-induced intestinal gas retention in irritable bowel syndrome. Gastroenterology 2002; 123:700-706. (Pubitemid 34977075)
35. Harder H, Hernando-Harder AC, Franke A, et al. Duodenal infusion of different nutrients and the site of gaseous stimulation influence intestinal gas dynamics. Scand J Gastroenterol 2006; 41:294-301.
36. Salvioli B, Serra J, Azpiroz F, Malagelada JR. Impaired small bowel gas propulsion in patients with bloating during intestinal lipid infusion. Am J Gastroenterol 2006; 101:1853-1857. (Pubitemid 44166597)
37. Harder H, Serra J, Azpiroz F, et al. Intestinal gas distribution determines abdominal symptoms. Gut 2003; 52:1708-1713. (Pubitemid 37510390)